Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2025-12-24 @ 3:41 PM
NCT ID:
NCT05449392
Eligibility Criteria:
Inclusion Criteria:
* Completion of written informed consent
* Covid-negative within 48 hours of enrollment based on PCR or Antigen test. If subjects are found to be positive, the PI will recommend appropriate follow-ups.
* In good general health as evidenced by medical history
* Ability to take Nasal medication and be willing to adhere to the nasal agent regimen
Exclusion Criteria:
* Participant with active nasal or respiratory symptoms.
* Participant with active or chronic respiratory nasal or respiratory infections and or is currently on antibiotics
* Participant who has been treated with oral or topical antibiotics with the past 14 days
* Participant who is on intranasal or oral corticosteroids or systemic immunosuppression medication
* Participant who has immunocompromised conditions such as rheumatological diseases, HIV, cancer on chemotherapy or biologic therapies.
* Participant who is on any intranasally applied medications (prescription or over the counter) including nonmedical nasal products and the use of Netipot or other nasal flush products.
* Participant with known allergic history to Neosporin (allergic history to neomycin or bacitracin or polymyxcin or pramoxine or the inactive ingredients that include cocoa butter, cottonseed oil, olive oil, sodium pyruvate, tocopheryl acetate and white petrolatum)
* Participant with known allergies to aminoglycoside antibiotics (neomycin, tobramycin, gentamycin, others)
* Participant with history of COVID-19 infection in the past 8 weeks.
* Participant who is pregnant
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT05449392
Study Brief:
Protocol Section:
NCT05449392